Revisor Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Revisor Wealth Management's LLY Position: Q3 2026 in Review
Revisor Wealth Management reduced its Eli Lilly (LLY) stake by 2.9% in Q3 2026, selling an estimated $24.8K and leaving 691 shares worth $853K. The position accounts for 0.21% of the portfolio, ranked #117.
Revisor Wealth Management first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.32M in Q1 2024. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Revisor Wealth Management held 691 shares of Eli Lilly worth $853K as of Q3 2026.
- Revisor Wealth Management sold 21 Eli Lilly shares in Q3 2026, an estimated $24.8K.
- Eli Lilly made up 0.21% of Revisor Wealth Management's portfolio in Q3 2026, its #117 holding.
- Revisor Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
- Revisor Wealth Management's Eli Lilly position peaked at $1.32M in Q1 2024.
- 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Revisor Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.